License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness Dublin, Ireland, and Tampere, Finland: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr Emmanuelle Charpentier, and StemSight Oy (‘StemSight’), a biotechnology […]
Integrates potency analysis and immunophenotyping to streamline cell therapy R&D Fully automated, standalone platform with single-cell resolution BOLOGNA, Italy – Cellply S.r.l. (Cellply) a leading developer of analytical tools for research and quality control within the “Cell Therapy” sector, today announced the launch of its flagship product VivaCyte.® VivaCyte – a tool capable of reducing development times, […]
PALO ALTO, CA — Bioz, Inc., a leading Silicon Valley-based AI software company committed to advancing scientific discovery, is excited to announce its partnership with Innovative Research. Innovative Research is a leading supplier of lab reagents, including plasma, serum, tissues, and proteins. The company’s impressive portfolio of over 65,000 high-quality human and animal biologicals has been cited in […]
Cytek’s Cutting-Edge Spectral Flow Cytometry Technology, Specialized Staff, Tools and Solutions Set New Benchmarks for Cell Analysis FREMONT, Calif. and BARCELONA, Spain — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, has signed an agreement with the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) to drive technological innovation and accelerate discoveries for the […]
Successful pilot programme results in government funding to embed rapid pathogen genomic sequencing capability into clinical research settings to improve patient outcomes and biosecurity. Oxford Nanopore Technologies today announced the completion and expansion of a successful pilot programme lead by a collaboration from across the genomics sector to deliver a respiratory metagenomics service with an […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the Board of Directors has elected Dalip M. Puri as Executive Vice President and Chief Financial Officer, effective April 2, 2024. Mr. Puri currently serves as Senior Vice President, Operational Finance. He will replace William J. Burke who has announced his retirement after 36 years with […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced that William J. Burke, AMETEK Executive Vice President and Chief Financial Officer, has decided to retire after 36 years of exceptional service, including nearly eight years as Chief Financial Officer. Mr. Burke’s retirement will be effective April 2, 2024. AMETEK’s Board of Directors has named Dalip M. […]
Automated parallel capillary electrophoresis system simplifies protein analysis. SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the release of a new automated parallel capillary electrophoresis system for protein analysis – the Agilent ProteoAnalyzer system – at the 23rd Annual PepTalk Conference, being held January 16-19 in San Diego. This new platform simplifies and improves the efficiency of analyzing complex […]
Analysis platform enables powerful, accessible single cell data exploration SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has acquired data analysis software company Biomage. With the acquisition, customers will have access to a richer suite of single cell data analysis tools through an intuitive interface. By […]
SAN JOSE – Complete Genomics, a life sciences company that provides novel, end-to-end DNA sequencing solutions, today announced a joint marketing agreement with Gencove, a pioneer of low-pass whole genome sequencing (lpWGS) imputation and analysis, to offer a bundled solution to deliver high-capacity and cost-effective whole genome information. The partnership will combine Gencove’s platform for data […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
